(Q35871158)

10 August 2017

1 reference

title

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus (English)

1 reference

10 August 2017

0 references

1 reference

2

Antona J Wagstaff

1 reference

10 August 2017

Neil A Reynolds

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

17

1 reference

10 August 2017

page(s)

1957-1974

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464170-00013

10 August 2017

exact match

0 references

cites work

Prevention of weight gain in type 2 diabetes requiring insulin treatment

1 reference

12 December 2020

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

1 reference

12 December 2020

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control

1 reference

12 December 2020

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of insulin aspart

1 reference

12 December 2020

Novel insulins: expanding options in diabetes management

1 reference

12 December 2020

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization

1 reference

12 December 2020

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

1 reference

12 December 2020

Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus

1 reference

12 December 2020

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

1 reference

12 December 2020

Treatment of diabetic ketoacidosis with subcutaneous insulin aspart

1 reference

12 December 2020

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects

1 reference

12 December 2020

A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes

1 reference

12 December 2020

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin

1 reference

12 December 2020

Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs

1 reference

12 December 2020

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

12 December 2020

The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients

1 reference

12 December 2020

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999

1 reference

12 December 2020

Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study

1 reference

12 December 2020

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

12 December 2020

Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes

1 reference

12 December 2020

Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes

1 reference

12 December 2020

A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

New insulins in the treatment of diabetes mellitus

1 reference

12 December 2020

Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus

1 reference

12 December 2020

Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes

1 reference

12 December 2020

Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes.

1 reference

12 December 2020

Insulin aspart: a novel rapid-acting human insulin analogue

1 reference

12 December 2020

A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes

1 reference

12 December 2020

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

12 December 2020

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study

1 reference

12 December 2020

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

12 December 2020

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

1 reference

12 December 2020

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers

1 reference

12 December 2020

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

12 December 2020

10.2165/00003495-200464170-00013

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1046186333

0 references

1 reference